专题:Phosphodiesterase function and regulation

This cluster of papers focuses on the molecular regulation and clinical applications of cyclic nucleotide phosphodiesterases (PDEs), particularly in the context of cAMP signaling, schizophrenia genetics, neuronal development, therapeutic targeting, compartmentalized signaling, Alzheimer's disease treatment, cardiac function regulation, and the development of phosphodiesterase inhibitors.
最新文献
近5年高被引文献
Recent advances in Alzheimer’s disease: mechanisms, clinical trials and new drug development strategies

article Full Text OpenAlex 1037 FWCI327.9448

Diagnosis and Treatment of Pulmonary Arterial Hypertension

article Full Text OpenAlex 688 FWCI77.5872

Alzheimer's disease drug development pipeline: 2022

article Full Text OpenAlex 684 FWCI69.2278

Alzheimer's disease drug development pipeline: 2024

article Full Text OpenAlex 309 FWCI72.2865

Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis

article Full Text OpenAlex 227 FWCI15.6955

Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis

article Full Text OpenAlex 195 FWCI74.7953

Receptor-associated independent cAMP nanodomains mediate spatiotemporal specificity of GPCR signaling

article Full Text OpenAlex 194 FWCI13.9796

Reimagining cholinergic therapy for Alzheimer’s disease

article Full Text OpenAlex 181 FWCI24.8884

Molecular hybridization: a powerful tool for multitarget drug discovery

article Full Text OpenAlex 173 FWCI27.0773

Nerandomilast in Patients with Progressive Pulmonary Fibrosis

article Full Text OpenAlex 168 FWCI119.2665